Recent Developments Raise Difficult Questions about Balancing Patient Access to Medication with Efforts to Limit Prescription Drug Costs: The Debate Over Limits on Manufacturer Support for Patient Expenses Is Far from Settled

Recent Developments Raise Difficult Questions about Balancing Patient Access to Medication with Efforts to Limit Prescription Drug Costs: The Debate Over Limits on Manufacturer Support for Patient Expenses Is Far from Settled

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of health care compliance 2018-01, Vol.20 (1), p.21
1. Verfasser: Furlow, Andrew
Format: Artikel
Sprache:eng
Schlagworte:
Economic aspects
Laws, regulations and rules
Pharmaceutical industry
Prescriptions (Drugs)
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 1
container_start_page 21
container_title Journal of health care compliance
container_volume 20
creator Furlow, Andrew
description
format Article
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A529947920</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A529947920</galeid><sourcerecordid>A529947920</sourcerecordid><originalsourceid>FETCH-LOGICAL-g1360-f1a2a65a5d874928207dbee5503aea6e7941a3dc8c3a8211ce403825188ae91e3</originalsourceid><addsrcrecordid>eNptkcFu2zAMhn3YgHXt3oHAgN08SHacyLtlSboVSNGu7c4FI1OOBlkyRLnd6-5NqqbD0AEBDyR-fv_PA98UJ7KpRKlqUb8r3jP_EkKqrJwUf25Ik0-wpgdyYRzyzHCDlgnW1hirJ5fgx0ScbPAMuAtTgq_o0Gvre7jGZJ_tS62JGVKAS-qsxmcaHm3aw8aYENNhtbWDTXAdiXW04wFZx6mHVeDEX-Bun2_SDhPB1QPFF5whU5foJ4M6TTHLt9M45kTIsf_Ob36P5JkYLhjOMYKJYYBbSslRd1a8NeiYPvztp8XP883d6nu5vfp2sVpuy17Wc1EaiRXOG2w6tZi1larEotsRNY2okXBOi3Ymse600jWqSkpNM1GrqpFKIbWS6tPi40tuj47urTchRdSDZX2_bKq2nS3aSmSqPEL15CmiC56MzfJ__OcjfK6OBquPGj69MuwJXdpzcNPhf6_BJ1tkquY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Recent Developments Raise Difficult Questions about Balancing Patient Access to Medication with Efforts to Limit Prescription Drug Costs: The Debate Over Limits on Manufacturer Support for Patient Expenses Is Far from Settled</title><source>Business Source Complete</source><creator>Furlow, Andrew</creator><creatorcontrib>Furlow, Andrew</creatorcontrib><identifier>ISSN: 1520-8303</identifier><language>eng</language><publisher>Aspen Publishers, Inc</publisher><subject>Economic aspects ; Laws, regulations and rules ; Pharmaceutical industry ; Prescriptions (Drugs)</subject><ispartof>Journal of health care compliance, 2018-01, Vol.20 (1), p.21</ispartof><rights>COPYRIGHT 2018 Aspen Publishers, Inc.</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>Furlow, Andrew</creatorcontrib><title>Recent Developments Raise Difficult Questions about Balancing Patient Access to Medication with Efforts to Limit Prescription Drug Costs: The Debate Over Limits on Manufacturer Support for Patient Expenses Is Far from Settled</title><title>Journal of health care compliance</title><subject>Economic aspects</subject><subject>Laws, regulations and rules</subject><subject>Pharmaceutical industry</subject><subject>Prescriptions (Drugs)</subject><issn>1520-8303</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNptkcFu2zAMhn3YgHXt3oHAgN08SHacyLtlSboVSNGu7c4FI1OOBlkyRLnd6-5NqqbD0AEBDyR-fv_PA98UJ7KpRKlqUb8r3jP_EkKqrJwUf25Ik0-wpgdyYRzyzHCDlgnW1hirJ5fgx0ScbPAMuAtTgq_o0Gvre7jGZJ_tS62JGVKAS-qsxmcaHm3aw8aYENNhtbWDTXAdiXW04wFZx6mHVeDEX-Bun2_SDhPB1QPFF5whU5foJ4M6TTHLt9M45kTIsf_Ob36P5JkYLhjOMYKJYYBbSslRd1a8NeiYPvztp8XP883d6nu5vfp2sVpuy17Wc1EaiRXOG2w6tZi1larEotsRNY2okXBOi3Ymse600jWqSkpNM1GrqpFKIbWS6tPi40tuj47urTchRdSDZX2_bKq2nS3aSmSqPEL15CmiC56MzfJ__OcjfK6OBquPGj69MuwJXdpzcNPhf6_BJ1tkquY</recordid><startdate>20180101</startdate><enddate>20180101</enddate><creator>Furlow, Andrew</creator><general>Aspen Publishers, Inc</general><scope/></search><sort><creationdate>20180101</creationdate><title>Recent Developments Raise Difficult Questions about Balancing Patient Access to Medication with Efforts to Limit Prescription Drug Costs: The Debate Over Limits on Manufacturer Support for Patient Expenses Is Far from Settled</title><author>Furlow, Andrew</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g1360-f1a2a65a5d874928207dbee5503aea6e7941a3dc8c3a8211ce403825188ae91e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Economic aspects</topic><topic>Laws, regulations and rules</topic><topic>Pharmaceutical industry</topic><topic>Prescriptions (Drugs)</topic><toplevel>online_resources</toplevel><creatorcontrib>Furlow, Andrew</creatorcontrib><jtitle>Journal of health care compliance</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Furlow, Andrew</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Recent Developments Raise Difficult Questions about Balancing Patient Access to Medication with Efforts to Limit Prescription Drug Costs: The Debate Over Limits on Manufacturer Support for Patient Expenses Is Far from Settled</atitle><jtitle>Journal of health care compliance</jtitle><date>2018-01-01</date><risdate>2018</risdate><volume>20</volume><issue>1</issue><spage>21</spage><pages>21-</pages><issn>1520-8303</issn><pub>Aspen Publishers, Inc</pub></addata></record>
fulltext fulltext
identifier ISSN: 1520-8303
ispartof Journal of health care compliance, 2018-01, Vol.20 (1), p.21
issn 1520-8303
language eng
recordid cdi_gale_infotracmisc_A529947920
source Business Source Complete
subjects Economic aspects
Laws, regulations and rules
Pharmaceutical industry
Prescriptions (Drugs)
title Recent Developments Raise Difficult Questions about Balancing Patient Access to Medication with Efforts to Limit Prescription Drug Costs: The Debate Over Limits on Manufacturer Support for Patient Expenses Is Far from Settled
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T17%3A39%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Recent%20Developments%20Raise%20Difficult%20Questions%20about%20Balancing%20Patient%20Access%20to%20Medication%20with%20Efforts%20to%20Limit%20Prescription%20Drug%20Costs:%20The%20Debate%20Over%20Limits%20on%20Manufacturer%20Support%20for%20Patient%20Expenses%20Is%20Far%20from%20Settled&rft.jtitle=Journal%20of%20health%20care%20compliance&rft.au=Furlow,%20Andrew&rft.date=2018-01-01&rft.volume=20&rft.issue=1&rft.spage=21&rft.pages=21-&rft.issn=1520-8303&rft_id=info:doi/&rft_dat=%3Cgale%3EA529947920%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A529947920&rfr_iscdi=true